Trial Profile
A new therapeutic approach to prevent acute insulin-mediated complications in type 2 diabetes Subtitle: The effect of the combination of the GLP-1 Analog Liraglutide and Insulin Levemir vs. Conventional Insulin Therapy [Neuer Therapieansatz zur Verhinderung akuter Komplikationen bei Typ 2 Diabetes: Der Effekteiner Kombination des GLP-1 Analogons Liraglutide mit Insulin Levemir im Vergleich zur konventionellen Insulintherapie]
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Aug 2012
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Liraglutide (Primary) ; Insulin aspart
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- Acronyms GALILEO
- 31 May 2012 New trial record